Blog - Page 634 of 658 - Prabadin Corp

January 14, 2025

Simultaneous quantitation and identification of intact Nandrolone phase II oxo‐metabolites based on derivatization and inject LC–MS/(HRMS) methodology

Accurate and convenient analysis of the intact phase II oxo-metabolites of nandrolone under the provisions of WADA’s TD2023IDCR was accomplished…

Drug Test

January 14, 2025

Systematic web monitoring of drug test subversion strategies in the United States

Systematic web monitoring of online discussions was used to investigate strategies to subvert drug testing. Urine specimens are often substituted…

Drug Test

January 14, 2025

Plasma drug screening using paper spray mass spectrometry with integrated solid phase extraction

Abstract Drug overdoses have risen dramatically in recent years. We developed a simple nontargeted method using a disposable paper spray…

Drug Test

January 14, 2025

A direct analysis method using sheath flow probe electrospray ionisation‐mass spectrometry (sfPESI‐MS) to detect drug residues from fingerprint forensic gel lifts

Sheath-flow probe electrospray ionisation mass spectrometry is applied to detect drug residues from forensic gel-lifted latent fingerprints. The sfPESI surface…

Drug Test

January 14, 2025

Establishing effective interpretation criteria in hair analysis to distinguish between passive and active cocaine exposure: Insights from authentic hair samples collected from professional individuals exposed to cocaine

Hair analysis for detecting cocaine can be challenging due to the need to differentiate between active use and passive contamination.…

outpatient-telemetry-correction:-philips-issues-correction-for-monitoring-service-application-used-with-mobile-cardiac-outpatient-telemetry-due-to-potential-for-missed-information-or-notifications-that-may-impact-patient-care

FDA

January 14, 2025

Outpatient Telemetry Correction: Philips Issues Correction for Monitoring Service Application used with Mobile Cardiac Outpatient Telemetry Due to Potential for Missed Information or Notifications That May Impact Patient Care

Philips Monitoring Service Application processes mobile cardiac telemetry data but failed to send critical data for review by healthcare professionals.